108 related articles for article (PubMed ID: 33767858)
1. VMAT for prostate cancer with 6-MV and 10-MV photons: Impact of beam energy on treatment plan quality and model-based secondary cancer risk estimates.
Mazonakis M; Kachris S; Damilakis J
Mol Clin Oncol; 2021 May; 14(5):89. PubMed ID: 33767858
[TBL] [Abstract][Full Text] [Related]
2. Secondary bladder and rectal cancer risk estimates following standard fractionated and moderately hypofractionated VMAT for prostate carcinoma.
Mazonakis M; Kachris S; Damilakis J
Med Phys; 2020 Jul; 47(7):2805-2813. PubMed ID: 32266979
[TBL] [Abstract][Full Text] [Related]
3. Risk for second bladder and rectal malignancies from cervical cancer irradiation.
Mazonakis M; Lyraraki E; Tolia M; Damilakis J
J Appl Clin Med Phys; 2021 Jul; 22(7):103-109. PubMed ID: 34021692
[TBL] [Abstract][Full Text] [Related]
4. The dosimetric effects of photon energy on the quality of prostate volumetric modulated arc therapy.
Mattes MD; Tai C; Lee A; Ashamalla H; Ikoro NC
Pract Radiat Oncol; 2014; 4(1):e39-44. PubMed ID: 24621430
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Radiation-Induced Bladder and Bowel Cancer Risks after Conventionally and Hypo-Fractionated Radiotherapy for the Preoperative Management of Rectal Carcinoma.
Matsali E; Pappas EP; Lyraraki E; Lymperopoulou G; Mazonakis M; Karaiskos P
J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143227
[TBL] [Abstract][Full Text] [Related]
6. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous optimization of mixed photon energy beams in volumetric modulated arc therapy.
Momin S; Gräfe J; Georgiou K; Khan R
Med Phys; 2019 Sep; 46(9):3844-3863. PubMed ID: 31276215
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric effect of photon beam energy on volumetric modulated arc therapy treatment plan quality due to body habitus in advanced prostate cancer.
Stanley DN; Popp T; Ha CS; Swanson GP; Eng TY; Papanikolaou N; Gutiérrez AN
Pract Radiat Oncol; 2015; 5(6):e625-33. PubMed ID: 26419443
[TBL] [Abstract][Full Text] [Related]
9. Treatment planning for radiotherapy with very high-energy electron beams and comparison of VHEE and VMAT plans.
Bazalova-Carter M; Qu B; Palma B; Hårdemark B; Hynning E; Jensen C; Maxim PG; Loo BW
Med Phys; 2015 May; 42(5):2615-25. PubMed ID: 25979053
[TBL] [Abstract][Full Text] [Related]
10. SU-E-T-578: Beam Energy Dependence and Intermediate-Low Dose Bath on Normal Tissue When Comparing VMAT with Conventional IMRT.
Qi P; Xia P
Med Phys; 2012 Jun; 39(6Part19):3838. PubMed ID: 28517072
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric and radiobiological comparison of prostate VMAT plans optimized using the photon and progressive resolution algorithm.
Chow JCL; Jiang R; Xu L
Med Dosim; 2020 Spring; 45(1):14-18. PubMed ID: 31103251
[TBL] [Abstract][Full Text] [Related]
12. Estimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes.
Zwahlen DR; Bischoff LI; Gruber G; Sumila M; Schneider U
Radiat Oncol; 2016 Nov; 11(1):149. PubMed ID: 27832799
[TBL] [Abstract][Full Text] [Related]
13. Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study.
Ost P; Speleers B; De Meerleer G; De Neve W; Fonteyne V; Villeirs G; De Gersem W
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):920-6. PubMed ID: 20675077
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a mixed beam therapy for postmastectomy breast cancer patients: Bolus electron conformal therapy combined with intensity modulated photon radiotherapy and volumetric modulated photon arc therapy.
Zhang R; Heins D; Sanders M; Guo B; Hogstrom K
Med Phys; 2018 Jul; 45(7):2912-2924. PubMed ID: 29749075
[TBL] [Abstract][Full Text] [Related]
15. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
[TBL] [Abstract][Full Text] [Related]
16. Radiation-Induced Second Cancer Risk from External Beam Photon Radiotherapy for Head and Neck Cancer: Impact on in-Field and Out-of-Field Organs.
Sakthivel V; Mani GK; Mani S; Boopathy R
Asian Pac J Cancer Prev; 2017 Jul; 18(7):1897-1903. PubMed ID: 28749618
[TBL] [Abstract][Full Text] [Related]
17. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
18. Improving plan quality for prostate volumetric-modulated arc therapy.
Wright K; Ferrari-Anderson J; Barry T; Bernard A; Brown E; Lehman M; Pryor D
Med Dosim; 2017 Winter; 42(4):348-356. PubMed ID: 28784431
[TBL] [Abstract][Full Text] [Related]
19. SU-E-T-574: Volumetric Modulated Arc Therapy for Prostate Radiation: A Dosimetric Comparison between VMAT Techniques and Fixed-Beam IMRT.
Qi S; Liu R; Lian J; Hu A; Song H
Med Phys; 2012 Jun; 39(6Part19):3837-3838. PubMed ID: 28517067
[TBL] [Abstract][Full Text] [Related]
20. Variation in accumulated dose of volumetric-modulated arc therapy for pancreatic cancer due to different beam starting phases.
Sasaki M; Nakamura M; Mukumoto N; Goto Y; Ishihara Y; Nakata M; Sugimoto N; Mizowaki T
J Appl Clin Med Phys; 2019 Oct; 20(10):118-126. PubMed ID: 31539194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
